A class
of rotaxane is created, not by encapsulating a conventional
linear thread, but rather by wrapping a large cucurbit[10]uril macrocycle
about a three-dimensional, cylindrical, nanosized, self-assembled
supramolecular helicate as the axle. The resulting pseudo-rotaxane
is readily converted into a proper interlocked rotaxane by adding
branch points to the helicate strands that form the surface of the
cylinder (like branches and roots on a tree trunk). The supramolecular
cylinder that forms the axle is itself a member of a unique and remarkable
class of helicate metallo-drugs that bind Y-shaped DNA junction structures
and induce cell death. While pseudo-rotaxanation does not modify the
DNA-binding properties, proper, mechanically-interlocked rotaxanation
transforms the DNA-binding and biological activity of the cylinder.
The ability of the cylinder to de-thread from the rotaxane (and thus
to bind DNA junction structures) is controlled by the extent of branching:
fully-branched cylinders are locked inside the cucurbit[10]uril macrocycle,
while cylinders with incomplete branch points can de-thread from the
rotaxane in response to competitor guests. The number of branch points
can thus afford kinetic control over the drug de-threading and release.
The untranslated regions (UTRs) of viral genomes contain av ariety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti-virals.W ecombine in vitro RNA analysis with molecular dynamics simulations to build the first 3D models of the structure and dynamics of key regions of the 5' UTR of the SARS-CoV-2 genome.F urthermore,w e determine the binding of metallo-supramolecular helicates (cylinders) to this RNAs tructure.T hese nano-sizea gents are uniquely able to thread through RNAjunctions and we identify their binding to a3 -base bulge and the central cross 4-way junction located in stem loop 5. Finally,w es how these RNAbinding cylinders suppress SARS-CoV-2 replication, highlighting their potential as novel anti-viral agents.
The untranslated regions (UTRs) of viral genomes contain a variety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti‐virals. We combine in vitro RNA analysis with molecular dynamics simulations to build the first 3D models of the structure and dynamics of key regions of the 5′ UTR of the SARS‐CoV‐2 genome. Furthermore, we determine the binding of metallo‐supramolecular helicates (cylinders) to this RNA structure. These nano‐size agents are uniquely able to thread through RNA junctions and we identify their binding to a 3‐base bulge and the central cross 4‐way junction located in stem loop 5. Finally, we show these RNA‐binding cylinders suppress SARS‐CoV‐2 replication, highlighting their potential as novel anti‐viral agents.
The untranslated regions (UTRs) of viral genomes contain a variety of conserved yet dynamic structures crucial for viral replication, providing drug targets for the development of broad spectrum anti-virals. We combine in vitro RNA analysis with Molecular Dynamics simulations to build the first 3D models of the structure and dynamics of key regions of the 5-prime UTR of the SARS-CoV-2 genome. Furthermore, we determine the binding of metallo-supramolecular helicates (cylinders) to this RNA structure. These nano-size agents are uniquely able to thread through RNA junctions and we identify their binding to a 3-base bulge and the central cross 4-way junction located in the stem loop 5. Finally, we show these RNA-binding cylinders suppress SARS-CoV-2 replication, highlighting their potential as novel anti-viral agents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.